Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-14

Clinical Trial Update: Artemisinin Partial Resistance in Ethiopian Plasmodium Falciparum: A Multisite Clinical, Molecular and In Vitro Study [NA]

View source ↗

Summary

Completed multisite study evaluating artemisinin partial resistance in Plasmodium falciparum from Ethiopia, including clinical, molecular, and in vitro analyses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin (Artemisinin)

Snippet

Sponsor: Didier Menard | Conditions: Malaria (Plasmodium Falciparum), Drug Resistance | NA | Status: COMPLETED